Other people moves come at Boston Scientific and FireFly Metals
Healthcare technology provider Resmed has named Salli Schwartz as its chief investor relations officer. She will report to Mick Farrell, the company’s CEO and chairman of the board.
Schwartz joins from biotech Illumina, where she was head of IR. Prior to that, she served as head of IR and treasurer at market data provider MSCI, where, along with her IR duties, she managed portfolios of cash, short-term investments and high-yield debt.
She has also been global head of IR and communications, among other roles, at Moody’s . . .
Log in FOR FREE to access this content
Log in or create your free My IR – Essentials account to:
- Access 50+ deep dives and best practice reports
- View 100+ news analyses and our exclusive CFO series
- Instantly benchmark your IR program with our new tool
- Save favorites and get tailored content delivered to your dashboard
- 10% off all IR forums!
Join now to make a real impact in your organization.
